Fonterra | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

38 results for “Fonterra”

Trials

View all 15 →

A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis

11 participants · First posted Apr 29, 2010

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

264 participants · First posted Dec 22, 2009

Enrolling By Invitation

Medtronic Enterra II Neurostimulator

500 participants · First posted Jan 22, 2024

Drugs

Gut'Innov platform(Da Volterra)

Gut'Fac platform(Da Volterra)

MYBPC3-targeting gene therapy (Frontera)

Organizations

View all 10 →

Fonterra Limited

Australia

FONTERRA CO-OPERATIVE GROUP LTD.

Bahrain

FONTERRA CO-OPERATIVE GROUP LIMITED

New Zealand

News

Vivici Secures €32.5M Series A to Launch Fermentation-Derived Lactoferrin in 2025

Superbrewed Food Launches Thryvia, a Shelf-Stable Protein-Derived Postbiotic for Gut and Immune Health

STALICLA Appoints Dr. Paulo Fontoura as Chief Scientific and Clinical Development Advisor

Page 1 of 4